Atomic Force Microscopy‐Based Nanomechanical Signatures for Staging Classification and Drug Response in Pulmonary Fibrosis
Small · 2025
DOI: 10.1002/smll.202504526 ↗Kurz gefasst
Fachartikel in der Zeitschrift Small, 2025. Verfasst von Andreas Stylianou und 11 weiteren Autor:innen. Beteiligte Einrichtung: Cancer Mechanobiology and Applied Biophysics Group, Basic and Translational Cancer Research Center (BTCRC), School of Sciences, European University C…. Hauptthemen laut MEDLINE: Microscopy, Atomic Force, Pulmonary Fibrosis. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: European Union, Research and Innovation Foundation, European Commission.
Abstract (Originalsprache)
Current therapies for pulmonary fibrosis (PF) show high variability in effectiveness, while the lack of specific biomarkers hinder early diagnosis, and treatment monitoring. With few approved drugs and inconsistent treatment responses, developing personalized therapies is essential. Since PF progression involves changes in tissue structure and mechanics, mechanobiology plays a central role. It is hypothesized that Atomic Force Microscopy (AFM) can identify unique nanomechanical fingerprints (NMFs) to characterize fibrosis stages and monitor treatment response. AFM is first used to assess NMFs in human biopsy samples, followed by evaluation in bleomycin‐induced murine PF models. NMFs are also studied in mice treated with pirfenidone, a drug known to reduce collagen I. AFM data are supported by histopathological staining, polarized and second harmonic generation (SHG) microscopy, and real‐time PCR analysis of collagen I expression. AFM measurements detected distinct NMFs in human samples and tracked alterations during PF progression in mice. Changes in NMFs correlated with collagen I content, histology, and SHG microscopy. In silico analysis supported NMFs’ potential as diagnostic biomarkers. Furthermore, AFM‐based NMFs assessed pirfenidone treatment outcomes. These findings provide the first evidence that AFM‐based NMFs can serve as biomarkers for PF staging and treatment monitoring, offering a powerful diagnostic tool to complement standard biopsies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Cancer Mechanobiology and Applied Biophysics Group, Basic and Translational Cancer Research Center (BTCRC), School of Sciences, European University Cyprus, Nicosia, 1516, Cyprus.
- EUC Research Center, Nicosia, 1516, Cyprus.
- Department of Electrical and Computer Engineering, National Technical University of Athens, Athens, 15780, Greece.
- Archimedes/Athena RC, Marousi, 15125, Greece.
- Cancer Biophysics Laboratory, Department of Mechanical and Manufacturing Engineering, University of Cyprus, Nicosia, 1678, Cyprus.
- Cancer Genetics, Therapeutics & Ultrastructural Pathology Department, The Cyprus Institute of Neurology and Genetics, Nicosia, 1683, Cyprus.
ORCID-Profile: Andreas Stylianou
Förderung
- European Union
- Research and Innovation Foundation
- European Commission
Zitieren
APA
Stylianou, A., Polemidiotou, K., Alimisis, V., Mpekris, F., Voutouri, C., Mari, M., Filippidis, G., Zachariades, A., Kontomaris, S. V., Sotiriadis, P. P., Gkretsi, V., & Stylianopoulos, T. (2025). Atomic Force Microscopy‐Based Nanomechanical Signatures for Staging Classification and Drug Response in Pulmonary Fibrosis. Small. https://doi.org/10.1002/smll.202504526
Vancouver
Stylianou A, Polemidiotou K, Alimisis V, Mpekris F, Voutouri C, Mari M, et al. Atomic Force Microscopy‐Based Nanomechanical Signatures for Staging Classification and Drug Response in Pulmonary Fibrosis. Small. 2025. doi:10.1002/smll.202504526
BibTeX
@article{Stylianou2025,
author = {Stylianou, Andreas and Polemidiotou, Katerina and Alimisis, Vassilis and Mpekris, Fotios and Voutouri, Chrysovalantis and Mari, Meropi and Filippidis, George and Zachariades, Andreas and Kontomaris, Stylianos-Vasileios and Sotiriadis, Paul P and Gkretsi, Vasiliki and Stylianopoulos, Triantafyllos},
title = {Atomic Force Microscopy‐Based Nanomechanical Signatures for Staging Classification and Drug Response in Pulmonary Fibrosis},
journal = {Small},
year = {2025},
doi = {10.1002/smll.202504526}
}
EUVIMED